NMLSF (Restart Life Sciences) Tariff Resilience Score: 6/10 (As of Jul. 01, 2026)


What is Restart Life Sciences Tariff Resilience Score?

Restart Life Sciences NMLSF -41.67% Tariff Resilience Score is 6 as of Jul. 01, 2026. The stock has 3 warning signs investors should review. Among 1,374 Biotechnology companies, Restart Life Sciences ranks better than 75.98% on this metric.

Restart Life Sciences has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Restart Life Sciences has Restart Life Sciences Corp has moderate exposure to tariffs due to its reliance on imported raw materials. It has some ability to switch suppliers and adjust pricing, providing moderate resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Restart Life Sciences might have Average Resilient.

Restart Life Sciences  (OTCPK:NMLSF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Restart Life Sciences Tariff Resilience Score Related Terms

NMLSF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Restart Life Sciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 6 mean?
Restart Life Sciences (NMLSF) has a Tariff Resilience Score of 6 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Restart Life Sciences ranks #330 out of 1374 companies in the Biotechnology industry, placing it in the top 24%.
Is Restart Life Sciences' Tariff Resilience Score too high?
Restart Life Sciences' current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Restart Life Sciences' value of 6 is 50% above this industry median. Based on the distribution chart, Restart Life Sciences ranks #330 out of 1374 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Restart Life Sciences' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Restart Life Sciences ranks #330 out of 1374 companies for Tariff Resilience Score. This places Restart Life Sciences in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Restart Life Sciences' value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Restart Life Sciences's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Restart Life Sciences's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Restart Life Sciences stock overvalued right now?
Restart Life Sciences (NMLSF) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Restart Life Sciences (NMLSF), the current Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Restart Life Sciences Business Description

Other Exchanges HEAL:Canada
Address 700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.